SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy

Current Pharmaceutical Biotechnology

Volumn 5, Issue 5, 2004, Pages 451-458

  Kimchi Sarfaty, Chava ^a   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Anti HIV gene therapy; Chemoprotection; High efficiency; Pigment epithelium derived factor; Pseudomonas exotoxin; SV40 in vitro packaging; SV40 vectors

Indexed keywords

ABC TRANSPORTER; ADENOVIRUS VECTOR; ALPHA2A INTERFERON; ANGIOGENESIS INHIBITOR; ANTIVIRUS AGENT; CALCEIN; CAPSID PROTEIN; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYTOSINE DEAMINASE; DNA VACCINE; DOXORUBICIN; FLUCYTOSINE; GLYCOPROTEIN GP 120; GLYCOPROTEIN P; LIPOSOME; MULTIDRUG RESISTANCE PROTEIN 1; NUCLEOTIDE; PACLITAXEL; PARVOVIRUS VECTOR; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMID DNA; POLYETHYLENEIMINE; RETROVIRUS VECTOR; RHODAMINE 123; RIBOZYME; SMALL INTERFERING RNA; TETRACYCLINE; THYMIDINE KINASE; UNINDEXED DRUG; VINBLASTINE; VIRUS DNA; VIRUS PROTEIN; VIRUS VECTOR;

ANTIVIRAL ACTIVITY; CANCER THERAPY; DNA SEQUENCE; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; IN VITRO STUDY; INSECT CELL; MOLECULAR WEIGHT; NONHUMAN; PLASMID; REVIEW; SIMIAN VIRUS 40; SUICIDE GENE; VIRAL GENE DELIVERY SYSTEM; VIRION; WILD TYPE;

ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL LINE; GENE TRANSFER TECHNIQUES; GENES, MDR; GENETIC VECTORS; HIV INFECTIONS; HUMANS; NEOPLASMS; SIMIAN VIRUS 40; TETRACYCLINE;

INSECTA; MUS MUSCULUS; PSEUDOMONAS;

EID: 4844220670     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389201043376670     Document Type: Review

References (63)

1. Tooze, J. DNA Tumor Viruses. 1981, New York: Cold Spring Harbor Laboratory.
2. Liddington, R.C.; Yan, Y.; Moulai, J.; Sahli, R.; Benjamin, T.L. and Harrison, S.C. (1991) Nature, 354(6351), 278-284.
3. Khalili, K.a.S., GL, Human Polyomaviruses. 2001, New York: Wiley-Liss, Inc.
4. Norkin, L.C. (1999) Immunol. Rev., 168, 13-22.
5. Norkin, L.C. (2001) Adv. Drug Deliv. Rev., 49(3), 301-315.
6. Norkin, L.C.; Anderson, H.A.; Wolfrom, S.A. and Oppenheim, A. (2002) J. Virol., 76(10), 5156-5166.
7. Pelkmans, L.; Kartenbeck, J. and Helenius, A. (2001) Nat. Cell Biol., 3(5), 473-483.
8. Pelkmans, L. and Helenius, A. (2002) Traffic, 3(5), 311-320.
9. Parton, R.G. and Lindsay, M. (1999) Immunol. Rev., 168(2), 23-31.
10. Chia, W. and Rigby, P.W. (1981) Proc. Natl. Acad. Sci. U S A, 78(11), 6638-6642.
11. Cordelier, P.; Calarota, S.A. and Strayer, D.S. (2002) J. Hematother. Stem Cell Res., 11(5), 817-828.
12. Gottesman, M.M. (2003) Cancer Gene Ther., 10(7), 501-508.
13. Dalyot-Herman, N.; Ben-nun-Shaul, O.; Gordon-Shaag, A. and Oppenheim, A. (1996) J. Mol. Biol., 259(1), 69-80.
14. Dalyot-Herman, N.; Rund, D. and Oppenheim, A. (1999) J. Hematother. Stem Cell Res., 8(6), 593-599.
15. Oppenheim, A. and Peleg, A. (1989) Gene, 77(1), 79-86.
16. Oppenheim, A.; Peleg, A.; Fibach, E. and Rachmilewitz, E.A. (1986) Proc. Natl. Acad. Sci. U S A, 83(18), 6925-6929.
17. Oppenheim, A.; Peleg, A. and Rachmilewitz, E.A. (1987) Ann. N Y Acad. Sci., 511418-427.
18. Strayer, D.S. (1996) J. Biol. Chem., 271(40), 24741-24746.
19. Strayer, D.S. (1999) J. Cell Physiol., 181(3), 375-384.
20. Strayer, D.S. (2000) Methods Mol. Biol., 13361-74.
21. Strayer, D.S.; Pomerantz, R.J.; Yu, M.; Rosenzweig, M.; BouHamdan, M.; Yurasov, S.; Johnson, R.P. and Goldstein, H. (2000) Gene Ther., 7(10), 886-895.
22. Strayer, D.S.; Zern, M.A. and Chowdhury, J.R. (2002) Curr. Opin. Mol. Ther., 4(4), 313-323.
23. Rund, D.; Dagan, M.; Dalyot-Herman, N.; Kimchi-Sarfaty, C.; Schoenlein, P.V.; Gottesman, M.M. and Oppenheim, A. (1998) Hum. Gene Ther., 9(5), 649-657.
24. Arad, U.; Ben-Nun-Shaul, O.; El-Latif, M.A.; Nissim, O. and Oppenheim, A. (2002) Virology, 304(2), 155-159.
25. Strayer, D.S. (1999) J. Hematother Stem Cell Res., 8(6), 573-574.
26. Strayer, D.S.; Kondo, R.; Milano, J. and Duan, L.X. (1997) Gene Ther., 4(3), 219-225.
27. Strayer, D.S.; Lamothe, M.; Wei, D.; Milano, J. and Kondo, R. (2001) Methods Mol. Biol., 165103-117.
28. Sandalon, Z. and Oppenheim, A. (2001) Methods Mol. Biol., 165119-128.
29. Strayer, D.S.; Duan, L.X.; Ozaki, I.; Milano, J.; Bobraski, L.E. and Bagasra, O. (1997) Biotechniques, 22(3), 447-450.
30. Cordelier, P.; Zern, M.A. and Strayer, D.S. (2003) Gene Ther., 10(6), 467-477.
31. Gooding, L.R. (1977) J. Immunol., 118(3), 920-927.
32. Strayer, D.; Branco, F.; Zern, M.A.; Yam, P.; Calarota, S.A.; Nichols, C.N.; Zaia, J.A.; Rossi, J.; Li, H.; Parashar, B.; Ghosh, S. and Chowdhury, J.R. (2002) Mol. Ther., 6(2), 227-237.
33. Kimchi-Sarfaty, C.; Arora, M.; Sandalon, Z.; Oppenheim, A. and Gottesman, M.M. (2003) Hum. Gene Ther., 14(2), 167-177.
34. Kimchi-Sarfaty, C.; Ben-Nun-Shaul, O.; Rund, D.; Oppenheim, A. and Gottesman, M.M. (2002) Hum Gene Ther., 13(2), 299-310.
35. Sandalon, Z.; Dalyot-Herman, N.; Oppenheim, A.B. and Oppenheim, A. (1997) Hum. Gene Ther., 8(7), 843-849.
36. Sandalon, Z. and Oppenheim, A. (1997) Virology, 237(2), 414-421.
37. Wrobel, B.; Yosef, Y.; Oppenheim, A.B. and Oppenheim, A. (2000) J. Biotechnol., 84(3), 285-289.
38. Osterman, J.V.; Waddell, A. and Aposhian, H.V. (1970) Proc Natl. Acad. Sci. U S A, 67(1), 37-40.
39. Qasba, P.K. and Aposhian, H.V. (1971) Proc. Natl. Acad. Sci. U S A, 68(10), 2345-2349.
40. Slilaty, S.N. and Aposhian, H.V. (1983) Science, 220(4598), 725-727.
41. Colomar, M.C.; Degoumois-Sahli, C. and Beard, P. (1993) J. Virol., 67(5), 2779-2786.
42. Salunke, D.M.; Caspar, D.L. and Garcea, R.L. (1986) Cell, 46(6), 895-904.
43. Krauzewicz, N. and Griffin, B.E. (2000) Adv. Exp. Med. Biol., 465(13), 73-82.
44. Chromy, L.R.; Pipas, J.M. and Garcea, R.L. (2003) Proc. Natl. Acad. Sci. U S A, 100(18), 10477-10482.
45. Litman, T.; Druley, T.E.; Stein, W.D. and Bates, S.E. (2001) Cell. Mol. Life Sci., 58(7), 931-959.
46. Aran, J.M.; Pastan, I. and Gottesman, M.M. (1999) Adv. Pharmacol., 46(1), 1-42.
47. Gottesman, M.M.; Germann, U.A.; Aksentijevich, I.; Sugimoto, Y.; Cardarelli, C.O. and Pastan, I. (1994) Ann. N. Y. Acad. Sci., 716(7), 126-138; discussion 138-143.
48. Licht, T.; Gottesman, M.M. and Pastan, I. (1995) Cytokines Mol. Ther., 1(1), 11-20.
49. Bunting, K.D.; Galipeau, J.; Topham, D.; Benaim, E. and Sorrentino, B.P. (1998) Blood, 92(7), 2269-2279.
50. Strayer, D.S.; Branco, F.; Landre, J.; BouHamdan, M.; Shaheen, F. and Pomerantz, R.J. (2002) Mol. Ther., 5(1), 33-41.
51. Cordelier, P.; Van Bockstaele, E.; Calarota, S.A. and Strayer, D.S. (2003) Mol. Ther., 7(6), 801-810.
52. Goldstein, H.; Pettoello-Mantovani, M.; Anderson, C.M.; Cordelier, P.; Pomerantz, R.J. and Strayer, D.S. (2002) J. Infect. Dis., 185(10), 1425-1430.
53. Cordelier, P. and Strayer, D.S. (2003) Biochim. Biophys. Acta, 1638(3), 197-207.
54. Harvey, D.M. and Caskey, C.T. (1998) Curr. Opin. Chem. Biol., 2(4), 512-518.
55. Gossen, M. and Bujard, H. (1993) Nucleic Acids Res., 21(18), 4411-4412.
56. Gottesman, M.M. (2002) Annu. Rev. Med., 53615-627.
57. Aleman, C.; Annereau, J.P.; Liang, X.J.; Cardarelli, C.O.; Taylor, B.; Yin, J.J.; Aszalos, A. and Gottesman, M.M. (2003) Cancer Res., 63(12), 3084-3091.
58. Pastan, I. (2003) Cancer Immunol. Immunother., 52(5), 338-341.
59. Akiyama, S.; Fojo, A.; Hanover, J.A.; Pastan, I. and Gottesman, M.M. (1985) Somat. Cell Mol. Genet., 11(2), 117-126.
60. Gettins, P.G.; Simonovic, M. and Volz, K. (2002) Biol. Chem., 383(11), 1677-1682.
61. Gehlbach, P.; Demetriades, A.M.; Yamamoto, S.; Deering, T.; Duh, E.J.; Yang, H.S.; Cingolani, C.; Lai, H.; Wei, L. and Campochiaro, P.A. (2003) Gene Ther., 10(8), 637-646.
62. Stellmach, V.; Crawford, S.E.; Zhou, W. and Bouck, N. (2001) Proc. Natl. Acad. Sci. U S A, 98(5), 2593-2597.
63. Yabe, T.; Wilson, D. and Schwartz, J.P. (2001) J. Biol. Chem., 276(46), 43313-43319.